Filing Details

Accession Number:
0001209191-14-033769
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-14 17:06:34
Reporting Period:
2014-05-12
Filing Date:
2014-05-14
Accepted Time:
2014-05-14 17:06:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1469029 A Jonathan Leff 3280 Bayshore Blvd
Brisbane CA 94005
Evp, Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-12 3,131 $36.14 42,748 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.